Praxis Precision Medicines Inc annual free cash flow for fiscal TTM was -$283 million, a decrease of 13.7% from -$249 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($283M) | ($249M) | ($132M) | ($111M) | ($185M) | ($126M) | ($53M) | ($33M) | ($21M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($79M) | ($86M) | ($77M) | ($65M) | ($55M) | ($53M) | ($56M) | ($28M) | ($27M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PRAX metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All PRAX financial statements → Interactive PRAX charts →
About TickerBase · Data methodology & sources · Privacy · Terms